Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation.
Rusha BhandariJennifer Berano TehTianhui HeRyotaro NakamuraAndrew S ArtzMarta M JankowskaStephen J FormanF Lennie WongSaro H ArmenianPublished in: Journal of the National Cancer Institute (2022)
High social vulnerability independently associated with 1-year NRM after HCT, specifically among minority populations and those with a high comorbidity burden at HCT. These findings may inform targeted approaches for needs assessment during and after HCT, allowing for timely interventions to improve health outcomes in at-risk patients.